F11R and cancer: The pleiotropic function that JAM-A dysregulation has in CRC compared to other cancer types may relate to tissue-specific differences in transcriptome and miRNAome [50] as well as the intracellular signalling pathways and downstream genes affected by JAM-A downmodulation.